AroCell

Xia Jiang has extensive international experience in the In Vitro Diagnostics (IVD) sector, managing key distribution channels across multiple regions including Asia-Pacific, Europe, Africa, and NGOs. She has a proven ability to establish and expand distribution networks in new markets, achieving significant revenue growth. Xia Jiang has a broad understanding of diverse healthcare systems, cultural environments, and distribution requirements.

Xia Jiang’s most recent experience includes business development at Actim, part of the Medix Biochemica Group. Previously, Xia held key roles at Aidian and Optomed Oy, where she was based both in Finland and China.

"I am eager to begin working with IDL Diagnostics in this interesting phase that the company is in," says Xia Jiang “I look forward to leveraging my knowledge and experience to help drive the expansion of our global sales.”

"I am delighted that Xia Jiang has chosen to join IDL Diagnostics," says Anders Hultman, CEO of IDL Diagnostics. "With Xia Jiang’s extensive international background in sales and business development, she will play a pivotal role in expanding our presence in new markets. As IDL Diagnostics enters this phase of growth, bringing Xia Jiang on board significantly enhances our sales capabilities and our potential for success," concludes Anders Hultman.